Image of GILEAD HIV Logo

Ending the HIV Epidemic (EHE) Masterclass

If Not Now, When? Sustaining Urgency in Helping End the HIV Epidemic

Progress and Challenges in HELPING END the HIV Epidemic

This EHE Masterclass—part of our Blueprints for Success Training Institute series—focuses on the extensive progress that has been made toward helping end the HIV epidemic, challenges that remain, and strategies to overcome these hurdles. Presenter Dr Oni Blackstock discusses global- and national-level goals toward helping end the HIV epidemic, and presenter Greg Millett examines regional and demographic HIV hotspots and how health disparity can act as barriers. To conclude the masterclass, Dr Patrick Sullivan moderates an engaging conversation between these two HIV leaders on ways to continue making progress.

Click to play the EHE Masterclass Video

If Not Now, When? Sustaining Urgency in Helping End the HIV Epidemic

Moderator: Patrick Sullivan, DVM, PhD, Dipl. ACVM (Epi)
Speakers: Oni Blackstock, MD, MHS, and Greg Millett, MPH

*Viral suppression means the amount of virus in the blood is very low or cannot be measured by a test (<200 c/mL). Viral suppression is the goal of HIV care and treatment.13

Back to Top
  1. Dawson L, Kates J. Delivering HIV care and prevention in the COVID era: a national survey of Ryan White providers. Kaiser Family Foundation (KFF) Issue Brief. Published December 16, 2020. Accessed May 20, 2022.
    https://www.kff.org/hivaids/issue-brief/delivering-hiv-care-prevention-in-the-covid-era-a-national-survey-of-ryan-white-providers/
  2. KFF. Status of state action on the Medicaid expansion decision—April 26, 2022. Published 2022. Accessed May 16, 2022.
    https://www.kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/
  3. KFF. Health insurance coverage of the total population—2019. Published 2022. Accessed May 16, 2022.
    https://www.kff.org/other/state-indicator/total-population/?currentTimeframe=0&selectedDistributions=employer--medicaid--medicare--uninsured&sortModel=%7B%22colId%22:%22Uninsured%22,%22sort%22:%22desc%22%7D#notes
  4. IQVIA LAAD Mx claims. Data on file. Gilead Sciences, Inc.
  5. Poteat T, Millett GA, Nelson LE, Beyrer C. Understanding COVID-19 risks and vulnerabilities among Black communities in America: the lethal force of syndemics. Ann Epidemiol. 2020;47:1-3. doi:10.1016/j.annepidem.2020.05.004
  6. National Academies of Sciences, Engineering, and Medicine. Investing in Interventions That Address Non-Medical, Health-Related Social Needs: Proceedings of a Workshop. Washington, DC: The National Academies Press; 2019. https://doi.org/10.17226/25544
  7. Macrotrends.net. Houston metro area population 1950-2022. Accessed May 19, 2022.
    https://www.macrotrends.net/cities/23014/houston/population
  8. United States Census. 2020 population and housing state data. Published August 12, 2021. Accessed May 19, 2022.
    https://www.census.gov/library/visualizations/interactive/2020-population-and-housing-state-data.html
  9. Telekind. How it works. A Program of Texas Health Action. Accessed May 16, 2022.
    https://www.mytelekind.org/how-it-works/
  10. The White House. 2021. National HIV/AIDS Strategy for the United States 2022–2025. Washington, DC. Accessed May 20, 2022.
    https://www.whitehouse.gov/wp-content/uploads/2021/11/National-HIV-AIDS-Strategy.pdf
  11. Health Resources & Services Administration. Ending the HIV epidemic in the US. Updated March 2022. Accessed May 4, 2022.
    https://www.hrsa.gov/ending-hiv-epidemic
  12. US Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Updated January 20, 2022. Accessed March 23, 2022.
    https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/guidelines-adult-adolescent-arv.pdf

Join us on social

The information on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regulatory control, legal requirements, and/or medical practices may vary in other countries.

WHAT WE LIVE FOR, HEALTHYSEXUAL, RADIAN, COMPASS INITIATIVE, HIV AGE POSITIVELY, TRANSCEND, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc. All other marks referenced herein are the property of their respective owners. © 2022 Gilead Sciences, Inc. All rights reserved. US-UNBC-0995 11/22